BioSpace News Archive

BioMidwest

New pulmonary valve benefits quality, length of life

The FDA-approved valve consists of a catheter-based stent (called Alterra), an artificial heart valve (SAPIEN 3) and the opportunity to implant the stent and valve without the need for open-heart surgery.

August 8, 2023
·
3 min read
Drug Development

XBiotech Announces First Patient Begins Novel Natrunix Therapy in Phase II Rheumatoid Arthritis (RA) Clinical Trial

XBiotech Inc. (NASDAQ: XBIT) today began treating the first patient in a phase II, double-blind, placebo-controlled, randomized clinical study to evaluate Natrunix as a new treatment for Arthritis.

August 8, 2023
·
4 min read
Brainomix AI Technology Improves Access to Stroke Treatment across the NHS

More stroke patients are benefiting from life-changing treatment thanks to Brainomix’s e-Stroke AI platform, according to a recent report from the Oxford Academic Health Science Network (Oxford AHSN).

August 8, 2023
·
4 min read
Drug Development

Hemostemix Submits Its Retrospective Heart Study to Leading Stem Cell Journal and Has Prepared Its CLI Phase II Clinical Trial Manuscript for Peer Review

Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) is pleased to announce it submitted for publication its retrospective cardiomyopathy study to a leading stem cell journal.

August 8, 2023
·
6 min read
BioMidwest

MSU Health Care to Expand Services with In-House Laboratory

MSU Health Care Laboratories, a joint venture between MSU Health Care and Grand Rapids-based private equity firm Auxo Investment Partners, has announced that operations of the laboratory will begin in mid-August.

August 8, 2023
·
3 min read
Business

Kinnate Biopharma Inc. Reports Second Quarter 2023 Financial Results and Recent Corporate Updates

Kinnate Biopharma Inc., a clinical-stage precision oncology company, announced financial results for the second quarter of 2023 and recent corporate updates.

August 8, 2023
·
9 min read
Business

NeuroPace Reports Second Quarter 2023 Financial Results and Increases Full Year 2023 Revenue Guidance

NeuroPace, Inc., a commercial-stage medical device company focused on transforming the lives of people living with epilepsy, reported financial results for the second quarter ended June 30, 2023.

August 8, 2023
·
10 min read
Genetown

X4 Pharmaceuticals Announces Industry Veteran Dr. Christophe Arbet-Engels to Join as Chief Medical Officer

X4 Pharmaceuticals, Inc. announced that Christophe Arbet-Engels, MD, PhD, will be joining the company as its new Chief Medical Officer, bringing more than 25 years’ experience in strategic global drug development across a wide range of therapeutic areas including rare and orphan diseases.

August 8, 2023
·
6 min read
Business

PepGen Reports Second Quarter 2023 Financial Results and Recent Corporate Developments

PepGen Inc. today reported financial results for the second quarter ended June 30, 2023 and highlighted recent corporate developments.

August 8, 2023
·
8 min read
Business

Sofwave Medical Reports Second Quarter and First Half 2023 Financial Results and Recent Business Highlights

Sofwave Medical Ltd (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners worldwide, reported second quarter and first half fiscal 2023 financial results for the period ended June 30, 2023, and recent business highlights.

August 8, 2023
·
3 min read